PCTC
BIO icon

Perkins Coie Trust Company’s Bio-Rad Laboratories Class A BIO Stock Holding History

Perkins Coie Trust Company’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$7.55K Buy
+20
New +$6.98K ﹤0.01% 260
2023
Q4 		– Sell
-9
Closed -$3.23K – 330
2023
Q3 		$3.23K Buy
+9
New +$3.47K ﹤0.01% 312

Other funds holding BIO

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
SGH
Sivik Global Healthcare Greenwich, Connecticut $175M AUM 28.78% 1-Year Est. Return
Gateway Investment Advisers
Gateway Investment Advisers Cincinnati, Ohio $11B AUM 34.31% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
Atria Investments
Atria Investments Charlotte, North Carolina $10.3B AUM 19.62% 1-Year Est. Return
Concurrent Investment Advisors
Concurrent Investment Advisors Tampa, Florida $14.5B AUM 24.52% 1-Year Est. Return
FRA
Frank Rimerman Advisors Palo Alto, California $1.81B AUM 32.96% 1-Year Est. Return
State of Alaska Department of Revenue
State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
Blue Trust Inc
Blue Trust Inc Alpharetta, Georgia $9.51B AUM 13.02% 1-Year Est. Return

Perkins Coie Trust Company's BIO Position: Q3 2026 in Review

Perkins Coie Trust Company opened a new position in Bio-Rad Laboratories Class A (BIO) in Q3 2026: 20 shares worth $7.55K. The stake represents ﹤0.01% of the portfolio and ranks #260 among its holdings. This is a return to the name: Perkins Coie Trust Company previously reported a position in BIO as recently as Q3 2023.

Perkins Coie Trust Company first reported a position in BIO in Q3 2023 and has held it in 2 quarters since. 37 funds tracked by Wall St. Rank hold BIO as of Q3 2026.

  • Perkins Coie Trust Company held 20 shares of Bio-Rad Laboratories Class A worth $7.55K as of Q3 2026.
  • Bio-Rad Laboratories Class A was a new Perkins Coie Trust Company position in Q3 2026.
  • Bio-Rad Laboratories Class A made up ﹤0.01% of Perkins Coie Trust Company's portfolio in Q3 2026, its #260 holding.
  • Perkins Coie Trust Company first reported a position in Bio-Rad Laboratories Class A in Q3 2023 and has held it in 2 quarters since.
  • 37 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2026.

Based on Perkins Coie Trust Company's 13F filing for Q3 2026, filed 15 Oct 2026.